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Treatment Restrictions and the Risk of Death in 
Patients With Ischemic Stroke or Intracerebral 
Hemorrhage
Hendrik Reinink, MD, MSc; Burak Konya, BSc; Marjolein Geurts , MD, PhD; L. Jaap Kappelle, MD, PhD;  
H. Bart van der Worp, MD, PhD
BACKGROUND AND PURPOSE: Do-not-resuscitate (DNR) orders in the first 24 hours after intracerebral hemorrhage have been 
associated with an increased risk of early death. This relationship is less certain for ischemic stroke. We assessed the relation 
between treatment restrictions and mortality in patients with ischemic stroke and in patients with intracerebral hemorrhage. 
We focused on the timing of treatment restrictions after admission and the type of treatment restriction (DNR order versus 
more restrictive care).
METHODS: We retrospectively assessed demographic and clinical data, timing and type of treatment restrictions, and vital 
status at 3 months for 622 consecutive stroke patients primarily admitted to a Dutch university hospital. We used a Cox 
regression model, with adjustment for age, sex, comorbidities, and stroke type and severity.
RESULTS: Treatment restrictions were installed in 226 (36%) patients, more frequently after intracerebral hemorrhage (51%) 
than after ischemic stroke (32%). In 187 patients (83%), these were installed in the first 24 hours. Treatment restrictions 
installed within the first 24 hours after hospital admission and those installed later were independently associated with death 
at 90 days (adjusted hazard ratios, 5.41 [95% CI, 3.17–9.22] and 5.36 [95% CI, 2.20–13.05], respectively). Statistically 
significant associations were also found in patients with ischemic stroke and in patients with just an early DNR order. In those 
who died, the median time between a DNR order and death was 520 hours (interquartile range, 53–737).
CONCLUSIONS: The strong relation between treatment restrictions (including DNR orders) and death and the long median 
time between a DNR order and death suggest that this relation may, in part, be causal, possibly due to an overall lack of 
aggressive care.
Key Words: infarction ◼ mortality ◼ resuscitation ◼ stroke ◼ survival analysis
In North American studies, treatment restrictions in the first 24 hours after intracerebral hemorrhage (ICH) have been associated with an increased risk of early 
death.1–3 Avoidance of treatment restrictions during the 
first 5 days after ICH has been associated with a lower 
30-day mortality rate than predicted.4,5 In line with this, 
American guidelines for the management of ICH advo-
cate aggressive therapy without any treatment restriction 
in the first days after hospitalization.6
However, many uncertainties about the association 
between treatment restrictions and mortality after stroke 
remain. First, it is uncertain whether this association is 
also present in patients with ischemic stroke. Second, 
the relation between the timing of treatment restric-
tions and death remains largely unknown. Few studies 
have investigated the relation between treatment restric-
tions installed after the first day and clinical outcomes.7,8 
Third, information on the relation between different 
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types of treatment restriction and clinical outcomes is 
limited.8 Furthermore, only a small number of studies 
have assessed the frequency of treatment restrictions in 
patients with acute stroke in Europe,9–12 which may be 
different from that in North America as a result of demo-
graphic or cultural differences.
We assessed the frequency and types of treatment 
restriction in patients with acute ischemic stroke or ICH 
admitted to the stroke unit of a university hospital in the 
Netherlands. We also assessed whether any association 
between treatment restrictions and the risk of death at 
90 days is dependent on the timing of their installment.
METHODS
We retrospectively studied consecutive patients with acute 
ischemic stroke or ICH primarily admitted to the Stroke Unit 
of the University Medical Center in Utrecht, the Netherlands, 
between January 2016 and December 2018. Patients were 
excluded if the final diagnosis was transient ischemic attack, 
if they were referred from another hospital, or if they were 
admitted because of elective treatment (eg, carotid endar-
terectomy). In our center, all stroke patients (including those 
with ICH) are admitted to the stroke unit, unless mechanical 
ventilation is required. The study was evaluated by the Medical 
Ethics Committee of the hospital, and the need for informed 
consent was waived. To avoid the possibility of unintentionally 
sharing information that can be used to reidentify private infor-
mation, individual patient data of this monocenter study will not 
be made available to other researchers. Methods used in the 
analysis, such as scripts for statistical packages, are available 
from the first author upon reasonable request.
Records of eligible patients were manually searched by 
one investigator (B.K.) and were checked by a second inves-
tigator in case of uncertainty (H.R.). Information about patient 
characteristics (age, sex, ethnicity, and prestroke modified 
Rankin Scale [mRS]), stroke characteristics (type of stroke, 
score on the National Institutes of Health Stroke Scale, and 
Glasgow Coma Scale on admission), and functional outcome 
(score on the mRS at discharge and at 90 days [±30 days] 
after stroke onset) was automatically extracted from the 
patient files and manually complemented with information 
from the discharge letters. If functional outcome at 90 days 
was not available, the latest known poststroke mRS score was 
used. Prestroke comorbidity was quantified according to the 
Charlson Comorbidity Index.13
The date and time of presentation in the hospital and date 
and time of the installment of treatment restrictions were 
retrieved from the hospital charts. We coded treatment restric-
tions as early (installed within 24 hours after hospital admission) 
or late (installed later). Treatment restrictions were catego-
rized by type on the following ordinal scale: do-not-resuscitate 
(DNR) order, withhold admission to intensive care unit, with-
hold curative treatment of complications, and withhold artificial 
nutrition and hydration (ANH). In principle, treatment restric-
tions have no effect on patient monitoring, except for no-ANH 
orders, in which case measurements of vital signs are usually 
stopped. Whenever possible, the question whether a treatment 
restriction should be installed is discussed with every patient or 
the representative on admission to the stroke unit. Treatment 
restrictions are incremental (eg, a no-intensive-care-unit order 
is accompanied by a DNR order) and may be extended by the 
treating physician at any time during the hospital stay, after 
consultation with the patient or the representative.
For descriptive analyses, we compared the proportions of 
patients with a treatment restriction between patients with 
ischemic stroke and patients with ICH by the χ2 test. In addition, 
we calculated the median and mean times between hospital 
admission and treatment restrictions and between treatment 
restrictions and death (if applicable) and used Kaplan-Meier 
curves to visualize survival.
The primary outcome was death at 90 days (±30 days). We 
used a time-to-event analysis and compared the survival time 
between patients with and those without treatment restrictions. 
To avoid the inclusion of patients who were already moribund 
on admission in the analyses of the relation between early 
treatment restrictions and death at 90 days, we used the date 
and time 24 hours after hospital admission as the start of sur-
vival time (t=0). As a consequence, patients who were already 
moribund at first presentation in the hospital and died within 
24 hours were not included in this analysis, and only patients 
who survived the first 24 hours with a treatment restriction 
were compared with those who survived without a treatment 
restriction. We performed separate analyses for patients with 
ischemic stroke and for those with ICH and for the 4 types of 
treatment restriction present at t=0 separately.
To assess the effect of treatment restrictions installed later, 
we did separate analyses in which t=0 was moved to subse-
quent days after admission (48 hours, 72 hours, etc) up to 
1 week (168 hours) and compared survival time in patients 
without treatment restrictions to patients with treatment restric-
tions present at t=0. In this analysis, the treatment restrictions 
present at t=0 could be a continuation of early treatment 
restrictions. In an additional analysis, we selected patients with 
treatment restrictions installed after 24 hours and compared 
these with patients without treatment restrictions. For all analy-
sis of late treatment restrictions, we excluded patients who had 
orders to withhold artificial fluid and nutrition in place at t=0, as 
we considered these patients already moribund at this stage.
We used a Cox regression model, with adjustment for the 
following variables: age, sex, Charlson Comorbidity Index, 
type of stroke, National Institutes of Health Stroke Scale, 
and Glasgow Coma Scale (Eye+Motor score) at admission. 
Survival time was calculated from t=0 to the moment of death 
(if within 90 days). If patients survived, they were censored 
at the date of the final follow-up. If follow-up was missing, 
patients were censored at the latest known moment they were 
alive. We expressed associations as crude and adjusted hazard 
ratios (aHRs) with 95% CIs.
Nonstandard Abbreviations and Acronyms
aHR adjusted hazard ratio
ANH artificial nutrition and hydration
DNR do not resuscitate
ICH intracerebral hemorrhage
mRS modified Rankin Scale
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RESULTS
Of 1198 patients screened, a total of 576 were excluded 
from the analysis (Figure I in the Data Supplement). 
Ninety-four patients were excluded because they were 
primarily admitted to the intensive care unit. Three-month 
follow-up was available for 93 of these patients (25 with 
ischemic stroke and 68 with ICH). Of the ischemic stroke 
patients, 11 (44%) had died and 6 (24%) had reached 
functional independence (mRS score 0–2). Of the ICH 
patients, 51 (75%) had died and 2 (3%) had reached a 
functional independent state.
Six hundred twenty-two patients fulfilled the inclu-
sion criteria and were included in the main analyses. 
Treatment restrictions were installed in 226 patients 
(36%), and in 187 of these patients (83%), treatment 
restrictions were installed in the first 24 hours. In 43 
patients, restrictions were extended during the course 
of the admission. Treatment restrictions were more 
prevalent in patients with ICH (51%) than in those with 
ischemic stroke (32%; P<0.0001). Patients with treat-
ment restrictions were older, more often women, more 
often had prestroke handicap, and had more comorbidity 
and more severe stroke as illustrated by higher National 
Institutes of Health Stroke Scale and lower Glasgow 
Coma Scale scores on admission than patients without 
treatment restrictions (Table 1). The median time from 
admission to a DNR order was 3 hours (Table 2). In 
patients with ICH, 35 of 43 orders (81.4%) to withhold 
artificial hydration and nutrition were installed within 
the first 24 hours after hospital admission, versus 8 
of 28 orders (28.6%) in patients with ischemic stroke 
(Table 2).
Twenty-nine patients (14%) with treatment restric-
tions reached functional independence (mRS score 
0−2) at 90 days versus 248 (64%) patients without 
treatment restrictions (Figure 1). Patients with more 
extensive treatment restrictions had a higher risk of 
death and died earlier than those with a DNR order 
alone (Figure 2). In those who died after a DNR order, 
the median time between the order and death was 
520 hours (Table 3). After installing a no-ANH order, 
the mean survival time was 52 hours, with 50% of the 
patients dying in the first 24 hours.
Thirty patients (5%; 4 with ischemic stroke and 26 
with ICH) died within the first 24 hours after hospital 
admission. In 26 (87%) of these patients, death or poor 
prognosis was perceived imminent after evaluation in the 
Table 1. Baseline Characteristics
Overall 
(n=622)
Treatment  
Restriction (n=226)
No Treatment 
Restriction (n=396) P Value
Ischemic stroke 477 (77%) 152 (67%) 325 (82%) <0.001
Sex (male) 346 (56%) 100 (44%) 246 (62%) <0.001
Ethnicity 0.225
 White 570 (92%) 208 (92%) 362 (91%)  
 Non-White 52 (8%) 18 (8%) 34 (9%)
Age, y (mean+SD) 68.22 (15.78) 79.19 (9.30) 61.96 (15.30) <0.001
Prestroke mRS <0.001
 0 276 (44%) 39 (17%) 237 (60%)  
 1 88 (14%) 35 (15%) 53 (13%)
 2 95 (16%) 42 (19%) 53 (13%)
 3 73 (12%) 44 (19%) 29 (7%)
 4 45 (7%) 34 (15%) 11 (3%)
 5 5 (1%) 4 (2%) 1 (0.3%)
 Unknown 40 (6%) 28 (12%) 12 (3%)
Prestroke CCI <0.001
 0 232 (37%) 64 (28%) 168 (42%)  
 1 174 (28%) 64 (28%) 110 (28%)
 2 82 (13%) 35 (16%) 47 (12%)
 3 65 (10%) 28 (12%) 37 (9%)
 4 22 (4%) 9 (4%) 13 (3%)
 ≥5 47 (8%) 26 (12%) 21 (5%)
GCS (E+M) at admission 
(median+IQR)
 10 (9–10) 10 (8–10) 10 (10–10) <0.001
NIHSS at admission (median+IQR) 6 (3–13) 10 (5–18) 5 (2–10) <0.001
CCI indicates Charlson Comorbidity Index; GCS (E+M), eyes and motor score on the Glasgow Coma Scale; IQR, interquartile range; 
mRS, modified Rankin Scale; and NIHSS, National Institutes of Health Stroke Scale.
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emergency department, and these patients had immedi-
ate withdrawal from any curative treatment. They either 
died in the emergency department or were admitted to 
the regular ward for end-of-life care. In those who sur-
vived the first day, the presence of any treatment restric-
tion at 24 hours was independently associated with 
increased mortality at 90 days (aHR, 5.41 [95% CI, 
3.17–9.22]), even when patients with no-ANH orders 
were excluded (aHR, 4.57 [95% CI, 2.62–7.99]; Table 4). 
Hazard ratios for mortality increased with more extensive 
treatment restrictions.
The presence of just a DNR order at 24 hours after 
hospital admission was independently associated with 
death at 90 days (aHR, 2.46 [95% CI, 1.23–4.92]; 
Table 4). Of the 72 patients with just a DNR order at 
24 hours, 20 had died at 90 days follow-up. Of these, 
9 were discharged alive, and relevant information about 
the causes of their deaths was not available. In the 11 
patients who died during hospital admission, none of the 
deaths could realistically have been avoided by cardiopul-
monary resuscitation. Rather, their death was preceded 
by a gradually deteriorating clinical condition (eg, respira-
tory insufficiency or progressive loss of consciousness).
In patients with ischemic stroke, all types of early 
treatment restriction were associated with an increased 
risk of death at 90 days. In patients with ICH, this asso-
ciation was statistically significant for any treatment 
restriction after adjusting for baseline confounders but 
not when no-ANH orders were excluded (Table 4). It 
should be noted that only 15 patients with ICH had a 
DNR order only at 24 hours, which is too few to draw 
conclusions.
We found similar effect sizes when we moved t=0 to 
subsequent days in the first week after hospital submis-
sion (Table I in the Data Supplement). Effect sizes were 
comparable when we only considered patients with 
Table 2. Number and Timing of Treatment Restrictions
n
Hours From Admission, 
Median (IQR)
<12 h of Hospital 
Admission
<24 h of Hospital 
Admission
All treatment restrictions (n=278)
 DNR 93 3 (2–17) 68 (73%) 76 (82%)
 No ICU 94 6 (2–34) 56 (60%) 67 (71%)
 No curative treatment 20 6 (2–220) 11 (55%) 11 (55%)
 No ANH 71 4 (2–69) 40 (57%) 43 (61%)
Treatment restrictions in ICH patients (n=89)
 DNR 18 3 (2–17) 13 (72%) 15 (83%)
 No ICU 21 21 (2–66) 9 (43%) 12 (57%)
 No curative treatment 7 6 (2–222) 5 (71%) 5 (71%)
 No ANH 43 3 (1–6) 35 (81%) 35 (81%)
Treatment restrictions in ischemic stroke patients (n=189)
 DNR 75 3 (1–17) 55 (73%) 61 (81%)
 No ICU 73 5 (2–24) 47 (64%) 55 (75%)
 No curative treatment 13 42 (2–220) 6 (46%) 6 (46%)
 No ANH 28 55 (1–138) 5 (18%) 8 (29%)
Treatment restrictions are incremental, and only the most extended treatment restriction is shown (eg, no ICU order 
also includes a DNR order). ANH indicates artificial nutrition and hydration; DNR, do not resuscitate; ICH, intracerebral 
hemorrhage; ICU, intensive care unit; and IQR, interquartile range.
Figure 1. Distribution of score on the modified Rankin Scale (mRS) at 90 d in patients with any treatment restriction present vs 
no treatment restriction during the entire hospital stay.  
Patients with orders to withhold artificial fluids and nutrition are excluded.
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treatment restrictions installed later than 24 hours (aHR, 
5.36 [95% CI, 2.20–13.05]). For late treatment restric-
tions, patient numbers were too small to perform sub-
group analyses based on the type of stroke.
DISCUSSION
In this study, at a stroke unit of a university medical cen-
ter in the Netherlands, about one-third of the patients 
admitted with ischemic stroke or ICH had a treatment 
restriction installed during hospital admission. Having 
any treatment restriction was independently associated 
with an increased risk of death at 90 days. The large 
majority of patients with a DNR or no-intensive-care-
unit order survived up to 90 days, and in those who 
died, the median time from their installment to death 
was about 3 weeks, demonstrating that these orders 
were not only placed in patients in whom death was 
already imminent.
The prevalence of treatment restrictions in our cohort 
was comparable to that in a study in stroke patients in the 
United Kingdom (34%),10 and the prevalence in patients 
with ICH was comparable to that in an American study 
(45%)1 but different from those in Finnish (35.5%)9 and 
Chinese studies (8.4%).14 This may be explained by geo-
graphic or cultural differences but also by the use of dif-
ferent definitions of treatment restrictions.
No earlier study has assessed the association 
between early treatment restrictions and the risk of 
death in patients with ischemic stroke alone. In these 
patients, we found that all types of early treatment 
restriction (even just the installment of a DNR order) 
were associated with an increased risk of death at 90 
days. Not surprisingly, the relation appeared to become 
stronger with more extensive restrictions. Previous 
studies focused on the association between treatment 
restrictions and mortality after ICH. In contrast to these 
studies,1,2,12 we found no statistically significant relation 
Figure 2. Kaplan-Meijer survival curve for patient with different types of treatment restrictions.  
t=0 is the moment of installment of the treatment restriction. In patients with multiple treatment restrictions during hospital admission, only the 
latest treatment restriction was used. ANH indicates artificial nutrition and hydration; DNR, do not resuscitate; and ICU, intensive care unit.
Table 3. Survival Time (Hours) in Patients With Treatment Restrictions Who Died Within 90 Days
Median (IQR) Mean (SD) Minimum Maximum
All patients
 DNR 520 (53–737) 808 (289) 13 2363
 No ICU 537 (66–1327) 741 (138) 8 2435
 No curative treatment 182 (33–1477) 618 (208) 21 1862
 No ANH 24 (3–78) 52 (8) 0 279
Treatment restrictions are incremental. In patients with multiple treatment restrictions during hospital admission, only the latest treatment restriction 
was used. ANH indicates artificial nutrition and hydration; DNR, do not resuscitate; ICU, intensive care unit; and IQR, interquartile range.
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between treatment restrictions and mortality at 90 days 
in ICH patients after adjusting for baseline prognostic 
factors and when patients with an order to withhold arti-
ficial administration of fluids and nutrition were excluded. 
This may be due to the limited number of patients, in 
part, caused by the exclusion of patients who died within 
the first 24 hours of admission.
In addition, most previous studies have only assessed 
the association between treatment restrictions installed 
in the first day after hospital admission and mortality at 
90 days. We found that this association was comparable 
for treatment restrictions installed later during the first 
week after hospital admission. One older cohort study 
reported increasing in-hospital mortality rates for each 
successive day on which a DNR order was written during 
the first 7 days after admission.7 However, this study did 
not use a time-to-event analysis, and the increasing mor-
tality rates and effect sizes per day suggest that patients 
who had died on previous days were still included in the 
analysis of the consecutive days.
As treatment restrictions are likely to serve as a marker 
for adverse prognostic factors, we were not surprised to 
find that functional outcome was worse and survival time 
was shorter in patients with more extensive treatment 
restrictions. However, the strong and consistent relation-
ship between the presence of treatment restrictions and 
death found in our and in previous studies after correcting 
for important prognostic factors, even when considering 
only a DNR order, remains remarkable.1–3,7,15 Our finding 
that about one-third of patients with a DNR order were 
functionally independent at 90 days demonstrates that 
these orders are not exclusively installed in patients with 
a poor prognosis, and the long survival time in those who 
died after a DNR order suggests that their installment is 
not just a preterminal measure in moribund patients. In 
addition, a previous study that stratified stroke patients 
by prognostic factors found that the impact of a DNR 
order on mortality was greatest among patients with a 
more favorable outcome.7 In our view, this suggests that 
the relationship between a DNR order and death may, in 
part, be causal.
There are several possible other explanations for 
higher mortality rates in patients with treatment restric-
tions. Even though we adjusted for prognostic variables, 
important but unknown confounders for the relationship 
between treatment restrictions and death may not have 
been captured. Moreover, treatment restrictions might be 
a reflection of patient’s advanced wishes or family prefer-
ence to refrain from life-prolonging interventions after a 
disabling stroke. Unfortunately, we could not use infor-
mation about advance directives in our analysis, as this 
is not systematically collected in our stroke database or 
specifically documented in the hospital charts. However, 
advance directives are infrequent in the Netherlands: it 
has been estimated that around 7% of the general popu-
lation has an advance directive.16 In addition, a previous 
study in the Netherlands reported that around 2% of the 
patients with severe stroke admitted to the stroke unit 
had a treatment restriction in place before admission.17
It has also been suggested that treatment restrictions 
might be a proxy for overall lack of optimal care, creat-
ing a ripple effect with restrictions leading to an overall 
Table 4. Effect of Stroke Type and Extent of Treatment Restrictions on the Association Between Early Treatment Restrictions 
(<24 h) and Death at 90 Days
Death at 90 d Hazard Ratio (95% CI)
Treatment Restriction No Treatment Restriction Crude Adjusted
Full cohort (n=592)
 Any treatment restriction 74/158 (47%) 29/434 (7%) 10.14 (6.58–15.61) 5.41 (3.17–9.22)
 DNR+no ICU+no curative treatment 56/140 (40%) 29/434 (7%) 8.15 (5.20–12.79) 4.57 (2.62–7.99)
 DNR+no ICU 48/130 (37%) 29/434 (7%) 7.26 (4.57–11.52) 4.10 (2.32–7.26)
 DNR 20/72 (28%) 29/434 (7%) 5.05 (2.85–8.93) 2.46 (1.23–4.92)
Ischemic stroke (n=473)
 Any treatment restriction 49/118 (42%) 22/355 (6%) 9.28 (5.59–15.38) 6.59 (3.55–12.22)
 DNR+no ICU+no curative treatment 42/111 (38%) 22/355 (6%) 8.20 (4.89–13.77) 6.01 (3.17–11.39)
 DNR+no ICU 39/106 (37%) 22/355 (6%) 7.81 (4.62–13.19) 5.63 (2.95–10.73)
 DNR 16/57 (28%) 22/355 (6%) 5.56 (2.91–10.59) 3.93 (1.80–8.59)
ICH (n=119)
 Any treatment restriction 25/40 (63%) 7/79 (9%) 11.92 (5.12–27.77) 3.79 (1.16–12.34)
 DNR+no ICU+no curative treatment 14/29 (48%) 7/79 (9%) 7.92 (3.19–19.71) 1.50 (0.37–6.17)
 DNR+no ICU 9/24 (38%) 7/79 (9%) 5.55 (2.06–14.94) 0.71 (0.13–3.77)
 DNR 4/15 (27%) 7/79 (9%) 3.48 (1.02–11.91) 0.17 (0.014–2.08)
Patients who died <24 h are excluded (n=30 for full cohort). Hazard ratios are adjusted for age, sex, CCI, Comorbidity Index, NIHSS at admission, GCS at admission, 
at stroke type (if applicable). CCI indicates Charlson Comorbidity Index, DNR, do not resuscitate; GCS, Glasgow Coma Scale; ICH, intracerebral hemorrhage; ICU, 
intensive care unit; and NIHSS, National Institutes of Health Stroke Scale.
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milieu of nihilism that may influence attitudes of care for 
patients beyond the DNR orders themselves.18 Previous 
studies have demonstrated that patients with intracere-
bral hemorrhage9 or ischemic stroke10 who have a DNR 
order are less likely to be treated on a stroke unit or by 
specialist teams and, therefore, may indeed receive less 
optimal care. There is a potential risk of self-fulfilling 
prophecies if patients predicted to have a poor outcome 
have early limitations in care or withdrawal of support and 
subsequently die.19,20 It has been emphasized that clini-
cians should be aware of the limited accuracy of models 
predicting outcomes after ischemic stroke or ICH and 
on the potential impact of subsequent early treatment 
restrictions on the overall aggressiveness of care.21
The results of our study should raise further aware-
ness of the potential of an increased risk of death as an 
undesired side effect of treatment restrictions installed in 
the early phase after stroke and highlight the importance 
of avoiding limitations in care beyond that of the treat-
ment restriction itself.
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